COPD: preclinical models and emerging therapeutic targets

Area of Science:

• Pulmonary Medicine
• Preclinical Research

Background:

• Chronic obstructive pulmonary disease (COPD) is a major global health burden.
• Preclinical models are essential tools for studying COPD pathogenesis and evaluating therapies.

Purpose of the Study:

• To review key features of preclinical COPD models.
• To discuss therapeutic targets and approaches for COPD treatment.

Main Methods:

• Literature search of relevant publications on preclinical COPD models.
• Synthesis of information on COPD induction methods, cardiovascular effects, inflammation, and cell-based therapies.

Main Results:

• Common COPD induction methods include cigarette smoke (CS), proteases, and microorganisms.
• Models allow study of cardiovascular effects, airway remodeling, inflammation, and lung regeneration.
• Mesenchymal stromal cell therapy shows promise.

Conclusions:

• Preclinical COPD models are vital for advancing biological understanding and discovering therapeutic targets.
• Improved insights will lead to better COPD treatments, benefiting patients and reducing resource utilization.